Home/Filings/4/0001213900-24-033831
4//SEC Filing

Jermasek Douglas 4

Accession 0001213900-24-033831

CIK 0001766140other

Filed

Apr 16, 8:00 PM ET

Accepted

Apr 17, 4:32 PM ET

Size

5.4 KB

Accession

0001213900-24-033831

Insider Transaction Report

Form 4
Period: 2024-04-15
Jermasek Douglas
EVP of Corporate Strategy
Transactions
  • Award

    Stock Options

    2024-04-15+463,2501,973,250 total
    Exercise: $1.14Exp: 2034-04-15Common Stock (463,250 underlying)
Footnotes (1)
  • [F1]115,813 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.

Documents

1 file

Issuer

Unicycive Therapeutics, Inc.

CIK 0001766140

Entity typeother

Related Parties

1
  • filerCIK 0001955273

Filing Metadata

Form type
4
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:32 PM ET
Size
5.4 KB